Tesamorelin
Egrifta · TH9507
It is an approved drug for belly fat in a specific illness related to HIV — not a general fat burner. People still read about it for visceral fat. That is a clinician’s decision, and it is not the same as the labeled use.
Usual range
1–2 mg
Schedule
Once daily
Half-life
~26–38 minutes (effect longer via IGF-1)
How it is used
A real prescription people ask about for deep belly fat.
Subcutaneous
Evening, abdomen subq. Consistent clock time.
Approved trials ran 26–52 weeks. Off-label users often 12–16 weeks.
How to mix this vial
Typical vial 2 mg · 1 mL BAC
Brand kits use a supplied diluent. Compounded 2 mg vials + 2 mL → 1 mg/mL. 1 mg = 100 units.
Follow labeled kit storage. Compounded: fridge after mixing.
Side effects
- Arthralgia
- Edema
- Injection-site reactions
- Glucose elevation
- Paresthesia
Who should skip this
- Active malignancy
- Pregnancy
- Disruption of the hypothalamic-pituitary axis
Nutrition note
Watch fasting glucose. Protein-forward meals; limit late-night refined carbs.
Stacks
Often stacked with
Approved molecule (Egrifta) for a specific indication. Compounded copies are not the branded drug.
Peptipedia is an educational calculator, not medical advice. Many catalog entries are unapproved for human use. Approved molecules have labels that outrank this app. Do not use this to self-prescribe. Consult a licensed clinician. Not for anyone under 18, pregnant, or being treated for cancer.